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ABSTRACT 
BACK GROUND : 
 Oral cancer (OC) is one of the major health hazards in India, and 
approximately 80,000 new cases are diagnosed annually, mainly attributed to 
different forms of tobacco consumption. Oral cancer generally is preceded by 
early changes termed as oral potentially malignant disorders, such as 
leukoplakia, oral submucous fibrosis (OSMF). It has been established that oral 
potentially malignant disorders represent an increased risk of developing oral 
cancer with malignant transformation rates that vary from 0.6% to 36%. In 
recent years emphasis has been placed on detecting molecular markers 
(biomarkers) for oral cancer from body fluids such as serum, saliva and urine. 
Identification of molecular markers will help in diagnosing the neoplastic 
process at the initial stage. The present study was conducted to study the role 
of serum Levo - Fucose as an enzyme marker for oral cancer.  
AIMS AND OBJECTIVES : 
 To evaluate the levels of serum Levo Fucose in oral cancer patients 
and to compare the levels of serum Levo Fucose in various clinical stages of 
cancer and in potentially malignant disorders. To evaluate the effectiveness of 
serum Levo Fucose as a diagnostic marker for oral cancer. 
 
METHODOLOGY : 
 The study consists of 40 patients divided in to four groups. Group I 
consist of 10 healthy volunteers, Group II consist of 10 patients with oral 
potentially malignant disorder, Group III consist of 10 patients with oral 
cancer without nodal metastasis and Group IV consist of 10 patients with oral 
cancer with nodal metastasis. 5ml of blood is drawn from the study subjects. 
Serum was separated from the blood by centrifugation and used to estimate the 
levels of Levo-fucose. L-Fucose assay kit was used for estimation of fucose 
levels in the serum. Fucose estimation was done in an ELISA kit with 
wavelength set at 340 nm. The final readings were calculated to get the serum 
Levo Fucose level in mg%. 
RESULTS : 
 The result showed that there was a significant increase in serum levo 
fucose level in patients with oral cancer compared to oral potentially 
malignant disorders and healthy controls with a statistically significant p valve 
of p < 0.001. There was no significant increase in serum levo fucose in 
patients with oral potentially malignant disorders compared to healthy controls 
with the p value of p = 0.008. 
 
 
CONCLUSION : 
 Thus correlation was obtained between levo-fucose and oral cancer and 
the L-fucose levels can be used as a biomarker in identification of oral cancer. 
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